Literature DB >> 30658877

Standard dose epinephrine versus placebo in out of hospital cardiac arrest: A systematic review and meta-analysis.

Hannah Kempton1, Ruan Vlok2, Christopher Thang3, Thomas Melhuish4, Leigh White5.   

Abstract

INTRODUCTION: Out of hospital cardiac arrest (OHCA) is a time critical and heterogeneous presentation. The most appropriate management strategies remain an issue for debate. The aim of this systematic review and meta-analysis was to determine the association of epinephrine versus placebo with return of spontaneous circulation, survival to hospital admission, survival to hospital discharge and neurological outcomes in out of hospital cardiac arrest.
METHODS: A systematic review of five databases was performed from inception to August 2018. Only randomised controlled trials were considered eligible for inclusion. The primary outcome was survival to hospital discharge. Secondary outcomes were ROSC, survival to hospital admission, neurological function on discharge and three-month survival. All studies were assessed for level of evidence and risk of bias.
RESULTS: Five randomised controlled trials with 17,635 patients were identified for inclusion. Use of epinephrine was associated with increased ROSC (OR = 3.10; 95% CI = 2.16 to 4.45; I2 = 74%; p < 0.0001) and increased survival to hospital admission OR = 2.52; 95% CI = 1.63 to 3.88; I2 = 94%; p < 0.0001). However, epinephrine was not associated with increased survival to discharge (OR = 1.09; 95% CI = 0.48 to 2.47; I2 = 77%; p = 0.84) or differences in neurological outcomes (OR = 0.81; 95% CI = 0.34 to 1.96). DISCUSSION: This study was a systematic review and meta-analysis of epinephrine versus placebo in OHCA. The use of epinephrine was associated with improved ROSC and survival to hospital admission. However, use of epinephrine was not associated with a significant difference in survival to hospital discharge, neurological outcomes or survival to 3 months. Further research is required to control for the confounders during inpatient management.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Cardiopulmonary resuscitation; Epinephrine; Meta-analysis

Mesh:

Substances:

Year:  2019        PMID: 30658877     DOI: 10.1016/j.ajem.2018.12.055

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Influence of the prehospital administered dosage of epinephrine on the plasma levels of catecholamines in patients with out-of-hospital cardiac arrest.

Authors:  Jun Nakajima; Yusuke Sawada; Yuta Isshiki; Yumi Ichikawa; Kazunori Fukushima; Yuto Aramaki; Kiyohiro Oshima
Journal:  Heliyon       Date:  2021-08-05

Review 2.  Interventions to improve cardiopulmonary resuscitation: a review of meta-analyses and future agenda.

Authors:  Athanasios Chalkias; John P A Ioannidis
Journal:  Crit Care       Date:  2019-06-07       Impact factor: 9.097

Review 3.  Drug use during adult advanced cardiac life support: An overview of reviews.

Authors:  Hans Vandersmissen; Hanne Gworek; Philippe Dewolf; Marc Sabbe
Journal:  Resusc Plus       Date:  2021-08-13

4.  Impact of intraosseous versus intravenous resuscitation during in-hospital cardiac arrest: A retrospective study.

Authors:  Kevin T Schwalbach; Sylvia S Yong; R Chad Wade; Joseph Barney
Journal:  Resuscitation       Date:  2021-07-14       Impact factor: 5.262

5.  Ultra-early serum concentrations of neuronal and astroglial biomarkers predict poor neurological outcome after out-of-hospital cardiac arrest-a pilot neuroprognostic study.

Authors:  Karl W Huesgen; Yasmeen O Elmelige; Zhihui Yang; Muhammad Abdul Baker Chowdhury; Sarah Gul; Carolina B Maciel; Marie-Carmelle Elie-Turenne; Torben K Becker; Scott A Cohen; Amy Holland; Cindy Montero; Tian Zhu; Kevin K Wang; Joseph A Tyndall
Journal:  Resusc Plus       Date:  2021-06-08

6.  Relationship between the Plasma Levels of Catecholamines and Return of Spontaneous Circulation in Patients with Out-of-Hospital Cardiac Arrest.

Authors:  Yumi Ichikawa; Yusuke Sawada; Jun Nakajima; Yuta Isshiki; Kazunori Fukushima; Yuto Aramaki; Kiyohiro Oshima
Journal:  Emerg Med Int       Date:  2021-07-29       Impact factor: 1.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.